CYCLOHEXANO- AND CYCLOHEPTAPYRAZOLE DERIVATIVE COMPOUNDS, FOR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR

Disclosed are cyclohexano− and cycloheptapyrazole derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formulas (I), (Ia), (II) or (IIa): wherein the variables R, R1, R2, R3 and R4 are as defined in t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHOI, SOONGYOU, BARYZA, JEREMY, L, LADOUCEUR, GAETAN, H, VELTHUISEN, EMIL, COISH, PHILIP, WANG, YAMIN, COOK, JAMES, H. II
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CHOI, SOONGYOU
BARYZA, JEREMY, L
LADOUCEUR, GAETAN, H
VELTHUISEN, EMIL
COISH, PHILIP
WANG, YAMIN
COOK, JAMES, H. II
description Disclosed are cyclohexano− and cycloheptapyrazole derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formulas (I), (Ia), (II) or (IIa): wherein the variables R, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and or behaviors involving the 5−HT2C receptor. Disclosed are cyclohexano- and cycloheptapyrazole derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formulas I, Ia, II or IIa: wherein the variables R, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor. L'invention se rapporte à des composés dérivés de cyclohexano- et cycloheptapyrazole ou à des stéréoisomères purifiés ou mélanges de stéréoisomères de ces composés, ainsi qu'à leurs sels ou formes de type promédicaments. Ces composés sont représentés par les formules structurelles (I), (Ia), (II) ou (IIa), dans lesquelles les variables R, R1, R2, R3, R3' et R4 sont définies dans la spécification. Ces composés s'avèrent utiles pour le traitement ou la prévention des maladies et/ou comportements impliquant le récepteur 5-HT2c.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO03057213A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO03057213A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO03057213A23</originalsourceid><addsrcrecordid>eNqNjLEKwjAUALs4iPoPz91AbSnOj-SVBGpeSdLWupQicRKt1P9Hh36A08Fx3Dp5y15WrOmClgWgVbCIOmDdO7xyRaDImRaDaQkkn2turPIHKNlB4wmMBWU8oScP6D1Lg4EUdCZoCJqgEDpkEhzJ35TdNlndx8ccdws3yb6kILWI02uI8zTe4jN-ho7TPC1O2THHLP-n-QIa6TgW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CYCLOHEXANO- AND CYCLOHEPTAPYRAZOLE DERIVATIVE COMPOUNDS, FOR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR</title><source>esp@cenet</source><creator>CHOI, SOONGYOU ; BARYZA, JEREMY, L ; LADOUCEUR, GAETAN, H ; VELTHUISEN, EMIL ; COISH, PHILIP ; WANG, YAMIN ; COOK, JAMES, H. II</creator><creatorcontrib>CHOI, SOONGYOU ; BARYZA, JEREMY, L ; LADOUCEUR, GAETAN, H ; VELTHUISEN, EMIL ; COISH, PHILIP ; WANG, YAMIN ; COOK, JAMES, H. II</creatorcontrib><description>Disclosed are cyclohexano− and cycloheptapyrazole derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formulas (I), (Ia), (II) or (IIa): wherein the variables R, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and or behaviors involving the 5−HT2C receptor. Disclosed are cyclohexano- and cycloheptapyrazole derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formulas I, Ia, II or IIa: wherein the variables R, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor. L'invention se rapporte à des composés dérivés de cyclohexano- et cycloheptapyrazole ou à des stéréoisomères purifiés ou mélanges de stéréoisomères de ces composés, ainsi qu'à leurs sels ou formes de type promédicaments. Ces composés sont représentés par les formules structurelles (I), (Ia), (II) ou (IIa), dans lesquelles les variables R, R1, R2, R3, R3' et R4 sont définies dans la spécification. Ces composés s'avèrent utiles pour le traitement ou la prévention des maladies et/ou comportements impliquant le récepteur 5-HT2c.</description><edition>7</edition><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030717&amp;DB=EPODOC&amp;CC=WO&amp;NR=03057213A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030717&amp;DB=EPODOC&amp;CC=WO&amp;NR=03057213A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHOI, SOONGYOU</creatorcontrib><creatorcontrib>BARYZA, JEREMY, L</creatorcontrib><creatorcontrib>LADOUCEUR, GAETAN, H</creatorcontrib><creatorcontrib>VELTHUISEN, EMIL</creatorcontrib><creatorcontrib>COISH, PHILIP</creatorcontrib><creatorcontrib>WANG, YAMIN</creatorcontrib><creatorcontrib>COOK, JAMES, H. II</creatorcontrib><title>CYCLOHEXANO- AND CYCLOHEPTAPYRAZOLE DERIVATIVE COMPOUNDS, FOR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR</title><description>Disclosed are cyclohexano− and cycloheptapyrazole derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formulas (I), (Ia), (II) or (IIa): wherein the variables R, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and or behaviors involving the 5−HT2C receptor. Disclosed are cyclohexano- and cycloheptapyrazole derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formulas I, Ia, II or IIa: wherein the variables R, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor. L'invention se rapporte à des composés dérivés de cyclohexano- et cycloheptapyrazole ou à des stéréoisomères purifiés ou mélanges de stéréoisomères de ces composés, ainsi qu'à leurs sels ou formes de type promédicaments. Ces composés sont représentés par les formules structurelles (I), (Ia), (II) ou (IIa), dans lesquelles les variables R, R1, R2, R3, R3' et R4 sont définies dans la spécification. Ces composés s'avèrent utiles pour le traitement ou la prévention des maladies et/ou comportements impliquant le récepteur 5-HT2c.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjLEKwjAUALs4iPoPz91AbSnOj-SVBGpeSdLWupQicRKt1P9Hh36A08Fx3Dp5y15WrOmClgWgVbCIOmDdO7xyRaDImRaDaQkkn2turPIHKNlB4wmMBWU8oScP6D1Lg4EUdCZoCJqgEDpkEhzJ35TdNlndx8ccdws3yb6kILWI02uI8zTe4jN-ho7TPC1O2THHLP-n-QIa6TgW</recordid><startdate>20030717</startdate><enddate>20030717</enddate><creator>CHOI, SOONGYOU</creator><creator>BARYZA, JEREMY, L</creator><creator>LADOUCEUR, GAETAN, H</creator><creator>VELTHUISEN, EMIL</creator><creator>COISH, PHILIP</creator><creator>WANG, YAMIN</creator><creator>COOK, JAMES, H. II</creator><scope>EVB</scope></search><sort><creationdate>20030717</creationdate><title>CYCLOHEXANO- AND CYCLOHEPTAPYRAZOLE DERIVATIVE COMPOUNDS, FOR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR</title><author>CHOI, SOONGYOU ; BARYZA, JEREMY, L ; LADOUCEUR, GAETAN, H ; VELTHUISEN, EMIL ; COISH, PHILIP ; WANG, YAMIN ; COOK, JAMES, H. II</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO03057213A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2003</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>CHOI, SOONGYOU</creatorcontrib><creatorcontrib>BARYZA, JEREMY, L</creatorcontrib><creatorcontrib>LADOUCEUR, GAETAN, H</creatorcontrib><creatorcontrib>VELTHUISEN, EMIL</creatorcontrib><creatorcontrib>COISH, PHILIP</creatorcontrib><creatorcontrib>WANG, YAMIN</creatorcontrib><creatorcontrib>COOK, JAMES, H. II</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHOI, SOONGYOU</au><au>BARYZA, JEREMY, L</au><au>LADOUCEUR, GAETAN, H</au><au>VELTHUISEN, EMIL</au><au>COISH, PHILIP</au><au>WANG, YAMIN</au><au>COOK, JAMES, H. II</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CYCLOHEXANO- AND CYCLOHEPTAPYRAZOLE DERIVATIVE COMPOUNDS, FOR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR</title><date>2003-07-17</date><risdate>2003</risdate><abstract>Disclosed are cyclohexano− and cycloheptapyrazole derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formulas (I), (Ia), (II) or (IIa): wherein the variables R, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and or behaviors involving the 5−HT2C receptor. Disclosed are cyclohexano- and cycloheptapyrazole derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formulas I, Ia, II or IIa: wherein the variables R, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor. L'invention se rapporte à des composés dérivés de cyclohexano- et cycloheptapyrazole ou à des stéréoisomères purifiés ou mélanges de stéréoisomères de ces composés, ainsi qu'à leurs sels ou formes de type promédicaments. Ces composés sont représentés par les formules structurelles (I), (Ia), (II) ou (IIa), dans lesquelles les variables R, R1, R2, R3, R3' et R4 sont définies dans la spécification. Ces composés s'avèrent utiles pour le traitement ou la prévention des maladies et/ou comportements impliquant le récepteur 5-HT2c.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO03057213A2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title CYCLOHEXANO- AND CYCLOHEPTAPYRAZOLE DERIVATIVE COMPOUNDS, FOR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T02%3A55%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHOI,%20SOONGYOU&rft.date=2003-07-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO03057213A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true